Screening for Studies on Retinovascular Diseases

CompletedOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

March 6, 1998

Study Completion Date

July 2, 2008

Conditions
Diabetic RetinopathyMacular DegenerationPathologic NeovascularizationRetinal Disease
Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Eye Institute (NEI)

NIH

NCT00001733 - Screening for Studies on Retinovascular Diseases | Biotech Hunter | Biotech Hunter